Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Imaging, Three-Dimensional | 4 | 2018 | 680 | 1.10 | Why? |
| Image Enhancement | 3 | 2018 | 177 | 0.64 | Why? |
| Magnetic Resonance Angiography | 1 | 2018 | 282 | 0.63 | Why? |
| Gray Matter | 1 | 2017 | 150 | 0.63 | Why? |
| Magnetic Resonance Imaging | 4 | 2017 | 6551 | 0.58 | Why? |
| Contrast Media | 1 | 2018 | 1011 | 0.45 | Why? |
| Republic of Korea | 15 | 2021 | 5858 | 0.39 | Why? |
| Image Processing, Computer-Assisted | 1 | 2018 | 1383 | 0.38 | Why? |
| Image Interpretation, Computer-Assisted | 2 | 2011 | 665 | 0.35 | Why? |
| Artifacts | 2 | 2017 | 250 | 0.29 | Why? |
| Arrhythmias, Cardiac | 1 | 2018 | 2510 | 0.27 | Why? |
| Knee Joint | 2 | 2017 | 194 | 0.23 | Why? |
| Algorithms | 3 | 2018 | 7346 | 0.22 | Why? |
| Mass Screening | 2 | 2020 | 8005 | 0.22 | Why? |
| Pneumovirus | 1 | 2019 | 11 | 0.20 | Why? |
| Cobicistat | 1 | 2020 | 172 | 0.19 | Why? |
| Microscopy, Phase-Contrast | 1 | 2018 | 10 | 0.19 | Why? |
| ATPases Associated with Diverse Cellular Activities | 1 | 2017 | 10 | 0.18 | Why? |
| Peroxisomes | 1 | 2017 | 16 | 0.18 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.18 | Why? |
| Fats | 1 | 2017 | 5 | 0.17 | Why? |
| Bundle-Branch Block | 1 | 2018 | 127 | 0.17 | Why? |
| Arabidopsis Proteins | 1 | 2017 | 54 | 0.17 | Why? |
| Caffeine | 1 | 2018 | 67 | 0.17 | Why? |
| Arabidopsis | 1 | 2017 | 88 | 0.17 | Why? |
| Darunavir | 1 | 2020 | 477 | 0.16 | Why? |
| Lung Diseases, Interstitial | 2 | 2018 | 1476 | 0.16 | Why? |
| HIV Protease Inhibitors | 1 | 2020 | 434 | 0.16 | Why? |
| Phantoms, Imaging | 1 | 2017 | 146 | 0.16 | Why? |
| Vitamin K | 1 | 2018 | 263 | 0.16 | Why? |
| Signal-To-Noise Ratio | 1 | 2017 | 217 | 0.15 | Why? |
| Hospitals, Special | 1 | 2020 | 523 | 0.15 | Why? |
| Connective Tissue Diseases | 1 | 2018 | 187 | 0.15 | Why? |
| Tachycardia, Ventricular | 1 | 2018 | 251 | 0.15 | Why? |
| Pleural Effusion | 1 | 2020 | 680 | 0.14 | Why? |
| Brain | 1 | 2011 | 5133 | 0.13 | Why? |
| Cigarette Smoking | 1 | 2018 | 337 | 0.13 | Why? |
| Oximetry | 1 | 2018 | 658 | 0.12 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.12 | Why? |
| Water | 1 | 2017 | 765 | 0.12 | Why? |
| Orthomyxoviridae | 1 | 2020 | 1168 | 0.11 | Why? |
| Membrane Proteins | 2 | 2021 | 1733 | 0.11 | Why? |
| Calibration | 1 | 2011 | 307 | 0.11 | Why? |
| Pulmonary Disease, Chronic Obstructive | 2 | 2018 | 3832 | 0.10 | Why? |
| Thorax | 1 | 2020 | 1873 | 0.10 | Why? |
| Heart Ventricles | 1 | 2018 | 1139 | 0.10 | Why? |
| Feedback | 1 | 2011 | 317 | 0.10 | Why? |
| Personal Satisfaction | 1 | 2018 | 1243 | 0.09 | Why? |
| Ambulatory Care Facilities | 1 | 2020 | 2063 | 0.09 | Why? |
| Myocardium | 1 | 2020 | 2323 | 0.09 | Why? |
| Tertiary Care Centers | 3 | 2020 | 8248 | 0.09 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2017 | 1234 | 0.09 | Why? |
| Feasibility Studies | 1 | 2017 | 3467 | 0.09 | Why? |
| Electrocardiography | 2 | 2020 | 3957 | 0.09 | Why? |
| Anti-HIV Agents | 1 | 2020 | 2209 | 0.09 | Why? |
| Pneumonia, Viral | 9 | 2020 | 243684 | 0.08 | Why? |
| Hepatitis C | 1 | 2018 | 1514 | 0.08 | Why? |
| Community-Acquired Infections | 1 | 2019 | 2328 | 0.08 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.08 | Why? |
| International Classification of Diseases | 2 | 2018 | 265 | 0.07 | Why? |
| Retrospective Studies | 10 | 2021 | 105322 | 0.07 | Why? |
| Atrial Fibrillation | 1 | 2018 | 2320 | 0.07 | Why? |
| C-Reactive Protein | 4 | 2020 | 7972 | 0.07 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.07 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.06 | Why? |
| Humans | 24 | 2021 | 930598 | 0.06 | Why? |
| Hospital Mortality | 3 | 2021 | 22087 | 0.06 | Why? |
| Tuberculosis | 1 | 2018 | 2895 | 0.06 | Why? |
| Proportional Hazards Models | 3 | 2020 | 6543 | 0.06 | Why? |
| Pandemics | 9 | 2020 | 389249 | 0.06 | Why? |
| Severity of Illness Index | 5 | 2020 | 48226 | 0.06 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.05 | Why? |
| Kidney Failure, Chronic | 1 | 2017 | 3222 | 0.05 | Why? |
| Drosophila Proteins | 1 | 2021 | 67 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.05 | Why? |
| Lung Neoplasms | 1 | 2018 | 3228 | 0.05 | Why? |
| Acute Kidney Injury | 1 | 2020 | 5762 | 0.05 | Why? |
| Critical Illness | 2 | 2021 | 17281 | 0.05 | Why? |
| Renal Dialysis | 1 | 2017 | 4358 | 0.05 | Why? |
| Kaplan-Meier Estimate | 2 | 2020 | 4260 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.05 | Why? |
| Lymphocytosis | 1 | 2020 | 122 | 0.05 | Why? |
| Middle Aged | 14 | 2021 | 270681 | 0.05 | Why? |
| Age Factors | 4 | 2021 | 21039 | 0.05 | Why? |
| Creatine Kinase, MB Form | 1 | 2020 | 259 | 0.05 | Why? |
| Aged | 12 | 2021 | 215776 | 0.05 | Why? |
| APACHE | 1 | 2021 | 682 | 0.05 | Why? |
| Male | 16 | 2021 | 367725 | 0.04 | Why? |
| Pneumonia | 1 | 2018 | 5652 | 0.04 | Why? |
| Genetic Complementation Test | 1 | 2017 | 59 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.04 | Why? |
| Female | 16 | 2021 | 380317 | 0.04 | Why? |
| Respiratory Tract Infections | 1 | 2019 | 6817 | 0.04 | Why? |
| Electrodes | 1 | 2018 | 203 | 0.04 | Why? |
| Reproducibility of Results | 2 | 2011 | 11304 | 0.04 | Why? |
| Reverse Transcription | 1 | 2020 | 673 | 0.04 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.04 | Why? |
| Seeds | 1 | 2017 | 114 | 0.04 | Why? |
| Bed Occupancy | 1 | 2020 | 476 | 0.04 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
| International Normalized Ratio | 1 | 2018 | 300 | 0.04 | Why? |
| Prognosis | 4 | 2021 | 32490 | 0.04 | Why? |
| Homozygote | 1 | 2017 | 230 | 0.04 | Why? |
| Adult | 12 | 2020 | 244371 | 0.04 | Why? |
| Inservice Training | 1 | 2020 | 477 | 0.04 | Why? |
| Medical History Taking | 1 | 2018 | 350 | 0.04 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.04 | Why? |
| Hypertension | 1 | 2017 | 8895 | 0.04 | Why? |
| Disease-Free Survival | 1 | 2020 | 1654 | 0.04 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.04 | Why? |
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2020 | 436 | 0.04 | Why? |
| Survival Rate | 2 | 2020 | 9206 | 0.04 | Why? |
| Protein Stability | 1 | 2017 | 756 | 0.03 | Why? |
| Alanine Transaminase | 1 | 2020 | 1329 | 0.03 | Why? |
| Catheter Ablation | 1 | 2018 | 438 | 0.03 | Why? |
| Heart Injuries | 1 | 2020 | 608 | 0.03 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.03 | Why? |
| Aspartate Aminotransferases | 1 | 2020 | 1394 | 0.03 | Why? |
| Policy | 1 | 2021 | 1372 | 0.03 | Why? |
| Sensitivity and Specificity | 2 | 2011 | 22971 | 0.03 | Why? |
| Natriuretic Peptide, Brain | 1 | 2020 | 1215 | 0.03 | Why? |
| Influenza, Human | 1 | 2017 | 10779 | 0.03 | Why? |
| Hospital Bed Capacity | 1 | 2020 | 1300 | 0.03 | Why? |
| L-Lactate Dehydrogenase | 1 | 2020 | 1995 | 0.03 | Why? |
| Sex Factors | 2 | 2020 | 11014 | 0.03 | Why? |
| Troponin I | 1 | 2020 | 1298 | 0.03 | Why? |
| Propensity Score | 1 | 2020 | 2690 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Cost of Illness | 1 | 2021 | 1903 | 0.03 | Why? |
| Anisotropy | 1 | 2009 | 56 | 0.03 | Why? |
| Autophagy | 1 | 2017 | 960 | 0.02 | Why? |
| Peptide Fragments | 1 | 2020 | 2075 | 0.02 | Why? |
| Hospitals, Teaching | 1 | 2017 | 1609 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2020 | 5440 | 0.02 | Why? |
| Indoles | 1 | 2017 | 1243 | 0.02 | Why? |
| Tomography, X-Ray Computed | 3 | 2020 | 25144 | 0.02 | Why? |
| Odds Ratio | 1 | 2020 | 5861 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.02 | Why? |
| Temperature | 1 | 2017 | 2305 | 0.02 | Why? |
| Thrombocytopenia | 1 | 2020 | 2093 | 0.02 | Why? |
| Cough | 1 | 2020 | 4891 | 0.02 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2017 | 6049 | 0.02 | Why? |
| Logistic Models | 1 | 2020 | 9089 | 0.02 | Why? |
| Aging | 1 | 2020 | 3581 | 0.02 | Why? |
| Intensive Care Units | 2 | 2020 | 29594 | 0.02 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.02 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.01 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 5002 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.01 | Why? |
| Renin-Angiotensin System | 1 | 2017 | 3661 | 0.01 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.01 | Why? |
| Adolescent | 2 | 2020 | 86841 | 0.01 | Why? |
| Pregnancy | 1 | 2020 | 23879 | 0.01 | Why? |
| Pilot Projects | 1 | 2009 | 5182 | 0.01 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.01 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Animals | 1 | 2020 | 78931 | 0.01 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
Park's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(178)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(105)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_